Loading clinical trials...
Loading clinical trials...
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia With and Without FLT3 Mutation
Conditions
Interventions
Treatment patterns among AML patients
AML-related healthcare resources
Locations
1
United States
Sermo
Charlotte, North Carolina, United States
Start Date
June 2, 2014
Primary Completion Date
March 18, 2016
Completion Date
March 18, 2016
Last Updated
November 5, 2024
NCT06660368
NCT05143996
NCT05768932
NCT07198867
NCT06398457
NCT07023588
Lead Sponsor
Astellas Pharma Global Development, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions